Machine Learning

AI infrastructure firm GoodVision AI merges with Calisa Acquisition Corp to go public, aiming to solve the critical AI inference challenge with new capital.

With a $4.2M pre-seed, Italy's Mirai Robotics aims to solve the maritime industry's labor crisis and digitize the oceans with autonomous vessels.

Medicus Pharma's microneedle patch for basal cell carcinoma clears nearly three-quarters of lesions, offering a potential non-surgical alternative to the scalpel.

Streaming service Arena Radio challenges the industry by segregating AI music, denying it royalties, and championing a new 'pro-human' economic model.

A new surgical robot from Beijing's Healinno Tech uses AI and a high-pressure waterjet to treat prostate issues with unprecedented precision and safety.

iWrity promises to solve the indie author review crisis with a mutual support system. We investigate if this new tool is a breakthrough or a risk to authors.

The National Heart Institute becomes the first hospital in Malaysia to achieve the highest global standard for digital maturity, promising a new era of patient care.

With new data on CUE-401, a novel therapy inspired by Nobel-winning science, Cue Biopharma makes a high-stakes play to redefine autoimmune treatment.

At HIMSS26, Juno Health debuts its v25 EHR, leveraging AI, integrated RCM, and true interoperability to tackle clinician burnout and data silos.

The data governance firm launches its new 'agentic' platform, aiming to free enterprises from 'pilot purgatory' by unifying data, AI, and compliance.

Aviation innovator Skyryse announces a groundbreaking emergency autoland system for both helicopters and airplanes, promising to revolutionize flight safety.

Despite a massive paper loss, Sharplink amassed a huge ETH treasury and grew staking revenue, testing a new model for public company crypto exposure.

A new AI signature from Caris Life Sciences aims to guide first-line therapy for a deadly cancer, facing hurdles of clinical validation and adoption.

The massive rollout of hellocare.ai's platform aims to enhance patient safety and ease nursing shortages, marking a major leap into the future of healthcare.

As it prepares for a Nasdaq listing, quantum software firm Horizon Quantum brings in veterans from Apple, Grab, and Broadcom to navigate its public future.

A new non-thermal ablation technology shows long-term success in shrinking thyroid nodules with high patient satisfaction, potentially disrupting surgical norms.

With one trial halted and another beginning, the company focuses its cash and hopes on BBI-940, a novel drug targeting a fundamental driver of cancer.

A new AI-designed drug shows promise in selectively burning fat while preserving muscle, with a potential twice-yearly dosing schedule for obesity.

With record backlogs and surging demand from AI and energy transition, Quanta's March 31st event will reveal new targets shaping the future of infrastructure.

IDEAYA Biosciences begins a key trial for its targeted therapy IDE892, aiming to conquer hard-to-treat tumors and pivoting to focus on its proprietary assets.